United States Pharmaceuticals Market is Anticipated to Witness High Growth Owing to Growing Geriatric Population
The United States pharmaceuticals market consists of prescription and over-the-counter drugs sold in the country. Pharmaceuticals are used in prevention, diagnosis, treatment and mitigation of diseases. The growing geriatric population which is more susceptible to chronic diseases and increasing research and development spending by pharmaceutical companies are amongst the key factors driving the growth of this market. The United States pharmaceuticals Market is estimated to be valued at US$ 599.47 Bn in 2024 and is expected to exhibit a CAGR of 8.6% over the forecast period 2024–2031. Key Takeaways Key players operating in the United States pharmaceuticals are Johnson & Johnson, Pfizer, AbbVie, Merck, Bristol-Myers Squibb, Amgen, Eli Lilly, Novartis. These players are undertaking various strategic initiatives such as partnerships, mergers & acquisitions and new product launches to gain competitive advantage and strengthen their f...

Comments
Post a Comment